Rocket Pharmaceuticals, Inc.

RCKT·NasdaqGM·Healthcare
Compare
2.4800−0.0800 (−3.13%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours2.4655−0.0145 (−0.58%)Oct 12, 5:21 PM EDT

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close2.5600
Open2.5400
Day range2.46002.5950
52-week range2.42005.4500
Off day high−4.43%
Off 52-week high−54.50%
Volume2.30M
Avg. volume (3M)1.69M
Market cap272.24M
EPS (TTM)-0.1700
Forward P/E-1.90
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.50
Shares outstanding109.77M
Short interest16.80% of float
Earnings dateNov 5, 2026 (est.)
Analyst target8.5792
Profit margin0.00%

Against its peers

Compare in full ›
RCKT LXEO SLDB TNYA RNA RGNX
Market cap 272.24M 249.55M 719.48M 126.80M 140.44M 512.92M
P/E (TTM) — — — — — —
Forward P/E -1.9 -2.2 -3.9 -1.4 -1.0 -2.6
Price/book 0.7 1.0 1.9 1.8 0.7 5.9
Dividend yield — — — — — —
1-year change −26.22% −60.61% +14.31% −70.71% −43.05% −28.84%
Today −3.13% −5.88% −2.33% −2.55% −2.26% −3.72%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All RCKT news ›
MarketScreener·

Rocket Pharmaceuticals, Inc. Announces Executive Changes

Rocket Pharmaceuticals, Inc. announced that on June 24, 2026, John Militello informed the company of his resignation as Senior Controller, Treasurer and Principal Accounting Officer, effective July 7,... announced that on June 24, 2026,…

MarketScreener·

Rocket Pharmaceuticals, Inc. : Insider Transactions

Follow insider transactions on Rocket Pharmaceuticals, Inc. in real time. Filter by importance or transaction type and analyze the history on MarketScreener. Insider Transactions Rocket Pharmaceuticals, Inc. Biotechnology & Medical…

MarketScreener·Positive

Transcript : Rocket Pharmaceuticals, Inc. - Special Call

Presentation Operator MessageOperator Good day, and welcome to the Rocket Pharmaceuticals Investor Program Update on Danon disease and the RP-A501 pivotal Phase II trial. As a reminder, today's... Transcript : Rocket Pharmaceuticals, Inc.…

From articles in the 4Search news index.

In the news

29mentions in 30 days
27with it in the headline
Positivesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 29 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.